Status:

COMPLETED

e-Health Care Method for Patients With Osteogenesis Imperfecta (Tele OI)

Lead Sponsor:

Paulo Humberto Mem Martendal Vallandro Costa

Conditions:

Osteogenesis Imperfecta

Eligibility:

All Genders

3-60 years

Phase:

NA

Brief Summary

This work seeks to formalize the association between the use of technology and the effective treatment of patients with Osteogenesis Imperfecta, which has not yet been explored in the literature; and ...

Detailed Description

This is an Interventional Clinical Trial without a Control Group that was carried out in a population of patients with Osteogenesis Imperfecta. To implement this intervention in these patients, a peri...

Eligibility Criteria

Inclusion

  • Osteogenesis Imperfecta patients
  • Patients over 3 years old
  • Patients must have a smartphone with the possibility of internet access and the capacity to support the Google Meet program (used in teleconsultations).

Exclusion

  • Patients under 3 years of age
  • Patients without any access to any type of internet
  • Patients undergoing treatment with pamindronate
  • Patients who, due to their older age (above 60 years), were not familiar with a cell phone device to use our application and follow the therapy remotely

Key Trial Info

Start Date :

October 20 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 20 2023

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT06555536

Start Date

October 20 2022

End Date

October 20 2023

Last Update

August 16 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Santa Casa de São Paulo

São Paulo, São Paulo, Brazil, 01221-020